Top Story

Orphan drug status granted for therapy to prevent post-transplantation pancreatic islet loss

July 25, 2016

The FDA granted an orphan drug designation to Araim Pharmaceuticals for its Innate Repair Receptor activator ARA 290, according to a press release.

ARA 290 is intended for treatment to increase survival and improve function of pancreatic islets after transplantation.

In the Journals

HPS2-THIRVE analysis: Adding niacin with laropiprant to statin reduced survival, increased costs

July 25, 2016
Quality of life-adjusted survival was reduced and hospital costs rose due to the addition of extended-release niacin with laropiprant to statin-based therapy, according…

Denosumab reduces cortical porosity in women with postmenopausal osteoporosis

July 25, 2016
Cortical porosity of the proximal femur shaft was reduced in women treated with denosumab therapy, study data show. The reduced cortical porosity results in increased…

Mixed-meal tolerance, arginine stimulation tests reproducible

July 25, 2016
Standardized mixed-meal tolerance and arginine stimulation tests are useful for providing measurements of beta-cell function that are reproducible and complementary…

Researchers identify brain patterns that help people cope with stress

July 24, 2016
A team of researchers identified brain patterns that appear to underlie healthy emotional and behavioral responses to stress. Rajita Sinha, PhD, along with…
More News Headlines »

Diabetic Eye 2015: New Concepts in Screening, Managing, and Referral

This activity is supported by an educational grant from Allergan, Inc.

Despite a number of effective treatment options, diabetic eye disease is a leading cause of vision loss in the United…
More »
Meeting News Coverage

VIDEO: FLAT-SUGAR investigators continue to explore role of glucose variability in diabetes-related complications

June 13, 2016
More »
Highlights from ADA

Highlights from ADA


The Emerging Biosimilar Therapeutic Landscape: Scientific Foundations and Clinical Implications

This activity is supported by an educational grant from Boehringer-Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.

Recent processes have been established to facilitate the production, validation, and utilization of biosimilars…
More »
Current Issues
View the Current Issues